- Home
- Labeler Index
- U.s. Pharmaceuticals
- 63539-012
- NDC Crossover: 63539-012 Xeljanz
NDC Crossover 63539-012 Xeljanz
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Tofacitinib Citrate
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 63539-012 – Xeljanz, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Xeljanz
- OR Generic name: Tofacitinib
- AND the same Administration Route: oral
- OR Dosage Form: tablet, film coated
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0069-0501 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-0502 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1001 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1002 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1029 | Xeljanz | Tofacitinib | Solution | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
63539-016 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | Human Prescription Drug |
63539-501 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | Human Prescription Drug |
63539-502 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | Human Prescription Drug |